SCUBE2 and cancer: Moreover, loss of SCUBE2 expression in different cancers is associated with pathological progression, in terms of clinical stage, tumor size, vascular invasion, lymph node status, depth of invasion and histological grade, and it is an independent predictor of poor prognosis [148–151].